Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
Abstract Background The possibility to monitor patient's serum proteome during treatment can provide deepened understanding of the biology associated with response to specific drugs. Non‐invasive serum sampling provides an opportunity for sustainable repetitive sampling of patients, which allow...
Main Authors: | Lavanya Lokhande, Venera Kuci Emruli, Christian Winther Eskelund, Arne Kolstad, Martin Hutchings, Riikka Räty, Carsten Utoft Niemann, Kirsten Grønbæk, Mats Jerkeman, Sara Ek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1524 |
Similar Items
-
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
by: Lavanya Lokhande, et al.
Published: (2020-12-01) -
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity
by: Catja Freiburghaus, et al.
Published: (2018-04-01) -
Tackling Mantle Cell Lymphoma in Europe
by: Denis Horgan, et al.
Published: (2022-09-01) -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
by: avinash kumar singh, et al.
Published: (2013-02-01) -
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma
by: Alexander D. Heini, et al.
Published: (2022-09-01)